Erythropoietin: Multiple targets, actions, and modifying influences for biological and clinical consideration

Journal of Experimental Medicine

Volumn 210, Issue 2, 2013, Pages 205-208

  Broxmeyer, Hal E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; CD131 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 5 RECEPTOR; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; STAT5 PROTEIN;

CELL PROLIFERATION; ERYTHROBLAST; ERYTHROID CELL; HUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; ERYTHROID PRECURSOR CELLS; ERYTHROPOIESIS; ERYTHROPOIETIN; HEMATOLOGIC DISEASES; HUMANS; RECEPTORS, ERYTHROPOIETIN; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 84874557004     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20122760     Document Type: Review

References (29)

1. Brines, M., and A. Cerami. 2006. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney Int. 70:246-250. http://dx.doi.org/10.1038/sj.ki.5001546
2. Broxmeyer, H.E. 2011. Erythropoietin surprises: an immune saga. Immunity. 34:6-7. http://dx.doi.org/10.1016/j.immuni.2011.01.004
3. Broxmeyer, H.E., D.E. Williams, G. Hangoc, S. Cooper, S. Gillis, R.K. Shadduck, and D.C. Bicknell. 1987. Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colonystimulating factor 1, recombinant murine interleukin 3, and recombinant murine granulocyte/ macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA. 84:3871-3875. http://dx.doi.org/10.1073/pnas.84.11.3871
4. Broxmeyer, H.E., S. Cooper, L. Lu, G. Hangoc, D. Anderson, D. Cosman, S.D. Lyman, D.E. Williams. 1991. Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Blood. 77: 2142-2149.
5. Broxmeyer, H.E., H.A. Bruns, S. Zhang, S. Cooper, G. Hangoc, A.N. McKenzie, A.L. Dent, U. Schindler, L.K. Naeger, T. Hoey, M.H. Kaplan. 2002. Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M. Immunity. 16:815-825. http://dx.doi.org/10.1016/S1074-7613(02)00319-9
6. Broxmeyer, H.E., J. Hoggatt, H.A. O'Leary, C. Mantel, B.R. Chitteti, S. Cooper, S. Messina-Graham, G. Hangoc, S. Farag, S.L. Rohrabaugh, et al 2012. Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis. Nat. Med. 18:1786- 1796. http://dx.doi.org/10.1038/nm.2991
7. Choi, D., S.A. Schroer, S.Y. Lu, L. Wang, X. Wu, Y. Liu, Y. Zhang, H.Y. Gaisano, K.U. Wagner, H. Wu, et al 2010. Erythropoietin protects against diabetes through direct effects on pancreatic beta cells. J. Exp. Med. 207:2831-2842. http://dx.doi.org/10.1084/jem.20100665
8. Christopherson, K.W. II, G. Hangoc, H.E. Broxmeyer.2002. Cell surface peptidase CD26/ dipeptidylpeptidase IV regulates CXCL12/ stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J. Immunol. 169:7000-7008.
9. Christopherson, K.W. II, G. Hangoc, C.R. Mantel, H.E. Broxmeyer. 2004. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science. 305:1000-1003. http://dx.doi.org/10.1126/science.1097071
10. Dev, A., S.M. Byrne, R. Verma, P.G. Ashton-Rickardt, D.M. Wojchowski. 2012. Erythropoietindirected erythropoiesis depends upon serpin inhibition of erythroblast lysosomal cathepsins. J. Exp. Med. 210:225-232.
11. Hand, C.C., M. Brines. 2011. Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward? J. Investig. Med. 59:1073-1082.
12. Hedley, B.D., A.L. Allan, and A. Xenocostas. 2011. The role of erythropoietin and erythropoiesisstimulating agents in tumor progression. Clin. Cancer Res. 17:6373-6380. http://dx.doi.org/10.1158/1078-0432.CCR-10-2577
13. Kertesz, N., J. Wu, T.H. Chen, H.M. Sucov, H. Wu. 2004. The role of erythropoietin in regulating angiogenesis. Dev. Biol. 276: 101-110. http://dx.doi.org/10.1016/j.ydbio.2004.08.025
14. McGee, S.J., A.M. Havens, Y. Shiozawa, Y. Jung, R.S. Taichman.2012. Effects of erythropoietin on the bone microenvironment. Growth Factors. 30:22-28. http://dx.doi.org/ 10.3109/08977194.2011.637034
15. Nairz, M., A. Schroll, A.R. Moschen, T. Sonnweber, M. Theurl, I. Theurl, N. Taub, C. Jamnig, D. Neurauter, L.A. Huber, et al 2011. Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-?B-inducible immune pathways. Immunity. 34:61-74. http://dx.doi.org/ 10.1016/j.immuni.2011.01.002
16. Nairz, M., T. Sonnweber, A. Schroll, I. Theurl, G. Weiss. 2012. The pleiotropic effects of erythropoietin in infection and inflammation. Microbes Infect. 14:238-246. http://dx.doi.org/10.1016/j.micinf.2011.10.005
17. Oster, H.S., D. Neumann, M. Hoffman, M. Mittelman. 2012. Erythropoietin: the swinging pendulum. Leuk. Res. 36:939-944. http://dx.doi.org/10.1016/j.leukres.2012.04.017
18. Papayannopoulou, T., A.R. Migliaccio, J.L. Abkowitz, A.D. D'Andrea. 2009. Biology of erythropoiesis, erythroid differentiation, and maturation. In Hematology: Basic Principles and Practice. Fifth edition. R. Hoffman, E.J. Benz, Jr., S.J. Shattil, B. Furie, L.E. Silberstein, P. McGlave, H. Heslop, and J. Anastasi, editors. Elsevier Churchill Livingston, Philadelphia. 276-294.
19. Ribatti, D. 2010. Erythropoietin and tumor angiogenesis. Stem Cells Dev. 19:1-4. http://dx.doi.org/10.1089/scd.2009.0402
20. Rizzo, J.D., M. Brouwers, P. Hurley, J. Seidenfeld, M.O. Arcasoy, J.L. Spivak, C.L. Bennett, J. Bohlius, D. Evanchuk, M.J. Goode, et alAmerican Society of Hematology and the American Society of Clinical Oncology Practice Guideline Update Committee. 2010. American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood. 116:4045-4059. http://dx.doi.org/10.1182/blood-2010-08-300541
21. Sathyanarayana, P., A. Dev, J. Fang, E. Houde, O. Bogacheva, O. Bogachev, M. Menon, S. Browne, A. Pradeep, C. Emerson, D.M. Wojchowski. 2008. EPO receptor circuits for primary erythroblast survival. Blood. 111: 5390-5399. http://dx.doi.org/10.1182/blood-2007-10-119743
22. Shaheen, M., and H.E. Broxmeyer. 2009. The humoral regulation of hematopoiesis. In Hematology: Basic Principles and Practice. Fifth edition. R. Hoffman, E.J. Benz EJ Jr., S.J. Shattil, B. Furie, L.E. Silberstein, P. McGlave, H. Heslop, and J. Anastasi, editors. Elsevier Churchill Livingston, Philadelphia. 253-275.
23. Shaheen, M., and H.E. Broxmeyer. 2011. Hematopoietic Cytokines and Growth Factors. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E., Broxmeyer, editor. AABB Press, Bethesda, MD. 35?74.
24. Shaheen, M., and H.E. Broxmeyer. 2012. Principles of Cytokine Signaling. In Hematology: Basic Principles and Practice. Sixth edition. R. Hoffman, E.J. Benz EJ Jr., S.J. Shattil, B. Furie, L.E. Silberstein, P. McGlave, H. Heslop, and J. Anastasi, editors. Elsevier Churchill Livingston, Philadelphia. In Press.
25. Sytkowski, A.J. 2011. The neurobiology of erythropoietin. Cell. Mol. Neurobiol. 31:931-937. http://dx.doi.org/10.1007/s10571-011-9695-0
26. Szenajch, J., G. Wcislo, J.Y. Jeong, C. Szczylik, L. Feldman. 2010. The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells From clinic to bench - a critical review. Biochim. Biophys. Acta. 1806:82-95.
27. Vogel, J., M. Gassmann. 2011. Erythropoietic and non-erythropoietic functions of erythropoietin in mouse models. J. Physiol. 589:1259-1264. http://dx.doi.org/10.1113/jphysiol.2010.196147
28. Wojchowski, D.M., P. Sathyanarayana, and A. Dev. 2010. Erythropoietin receptor response circuits. Curr. Opin. Hematol. 17:169-176.
29. Zhang, Y.L., M.L. Radhakrishnan, X. Lu, A.W. Gross, B. Tidor, and H.F. Lodish. 2009. Symmetric signaling by an asymmetric 1 erythropoietin: 2 erythropoietin receptor complex. Mol. Cell. 33:266-274. http://dx.doi.org/10.1016/j.molcel.2008.11.026